Navigation Links
Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
Date:12/20/2007

e and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa- 2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of anthrax disease, and the Company is on track to begin the delivery in 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of cancers. The IAP inhibitor AEG40826 is expected to enter Phase 1 clinical trials for the treatment of cancer in early 2008.

For more information about Human Genome Sciences, please visit the Company's web site at http://www.hgsi.com. For more information about HGS-ETR1, see http://www.hgsi.com/products/ETR1.html. Health professionals interested in more information about trials involving HGS products are encouraged to inquire via the Contact Us section of the HGS website, http://www.hgsi.com/products/request.html, or by calling (301) 610-5790, extension 3550.

ABthrax, Albuferon, LymphoStat-B, HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.

HGS Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forw
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...5 The endangered black-footed ferr... This rare carnivore feeds on prairie dogs. The ...ten entire population die-offs in towns occur. Th...mented a ferret breeding program and has been rele... native habitat. Unfortunately, plague can sweep ...
(Date:11/5/2009)...ewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bull...s for the quarter ended September 30, 2009. The Co...les that follow. ,, Third Quarter 2009 ,, ...01 per share for the third quarter of 2009 as comp...for the third quarter of 2008. ,, Net sales we...
(Date:11/5/2009)... WaferGen Biosystems, Inc...of state-of-the-art genetic analysis systems, toda...ed the company,s Scientific Advisory Board. His c...izing novel molecular diagnostics for cancer detec...t of computational biology systems for several bio...
(Date:11/5/2009)...ke Sanders brings a new look to Pro Repro , ...2009 -- Professional Reprographics, Orange County&...leased to present Brooke Sanders to the company. B...alist. The addition of Brooke to the company repre...ssional Reprographics., , ,Brooke brings with her ...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...eeds to be used to support the achievement of seve...ilestones of Acasti Pharma, LAVAL, QC, Oct. 9 /PR...ptune Technologies & Bioressources Inc. ("Neptune"...he Company successfully completed as of,October 8,...le debentures,for gross proceeds of $2,750,000., ...
... Management Solution Will Help Commonwealth Care A...FORD, Mass., Oct. 9 Casenet, Inc., a provider of,...ay announced that,Commonwealth Care Alliance, a no...enet,s case management solution to more effectivel...osters collaboration and communication,between dir...
...any Announces Corporate Restructuring to Focus on ... and M&A, SAN DIEGO, Oct. 8 Nventa Biopharmaceut... innovative therapeutics for,the treatment of vira...on,its ongoing development programs. The company a...structuring that will extend the company,s financi...
Other Biology Technology:Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 3Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 4Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members 2Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members 3Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 2Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 3Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 4Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 5Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 6Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 7Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR 8
(Date:11/4/2009)...natural science) , United States Using Less Wa...oday than it did 35 years ago, despite a 30 percen...artly attributable to alternative cooling methods ...ems. According to the latest USGS water use report...es goes to cooling thermoelectric power plants. Ir...
(Date:11/4/2009)...y that deciphered the DNA codes, or genomes, of th...as joined The Genome 10K Project, an international...equences on 10,000 species of animals for conducti...an not be achieved. , Participating in The Genom...he Nov. 5, 2009 issue of the Journal of Heredity ...
(Date:11/4/2009)...., Oct. 20 DigitalPersona, Inc., a... solutions, today announced that WAND Corporation,...e for quick-service restaurants, has integrated Di... Classic POS solutions. WAND,s quick-service custo...ashier accountability and deter unauthorized manag...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Inhibition of NF kappa B a key inflammatory protein reduced radiation toxicity in zebrafish 55919 1Inhibition of NF kappa B a key inflammatory protein reduced radiation toxicity in zebrafish 55919 2SAGE to publish leading international headache journal Cephalalgia 55917 1SAGE to publish leading international headache journal Cephalalgia 55917 2Stuy in NEJM 3A New therapy prevents heart failure 55915 1Stuy in NEJM 3A New therapy prevents heart failure 55915 2
...e work of Forsyth scientist Peter Jezewski, DDS, P...ation of protein regions (,modules,) within ancien... of certain birth disorders. Tracing the history o...sx gene family over the past 600 million years has... origin of the human mouth. , Dr. Jezewski has p...
...io College-age football players who gain weight t... be setting themselves up for diabetes and heart d...rly half of a sample of collegiate offensive and d...for the study had metabolic syndrome. This means t... that indicate a person has higher chances of deve...
...kthroughs in the treatment of many common diseases...d by harnessing a powerful scientific approach cal...ts from across Europe. In a Science Policy Briefin...n, the scientists provide a detailed strategy for ...arch over the coming years. , Systems biology is ...
Other Biology News:Scientists uncover evolutionary keys to common birth disorders 2Athletes not spared from health risks of metabolic syndrome 2Athletes not spared from health risks of metabolic syndrome 3Key to future medical breakthroughs is systems biology, say leading European scientists 2Key to future medical breakthroughs is systems biology, say leading European scientists 3
PlusOne EDTA, disodium salt from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-p38 alpha Polyclonal Antibody, Unconjugated from R&D Systems
Chicken Anti-Human XBP1 Polyclonal Antibody, Unconjugated from ProSci, Inc
Mouse LIGHT / TNFSF14, Unconjugated from R&D Systems
Biology Products: